Bioprocess engineering

UK Government awards Clean Food Group funding for £1 million project to accelerate novel low-emission food production systems

Retrieved on: 
Tuesday, December 5, 2023

Clean Food Group is supporting the UK's broader mission to lead the global drive for innovative bio-tech solutions to deliver a more sustainable, secure and healthy food system

Key Points: 
  • Clean Food Group is supporting the UK's broader mission to lead the global drive for innovative bio-tech solutions to deliver a more sustainable, secure and healthy food system
    LONDON, Dec. 5, 2023 /PRNewswire/ -- Pioneering UK-based bio-tech business, Clean Food Group has been awarded funding for a £1 million project to advance novel low-emission food production systems in the UK.
  • The funding will enable the rapid scale up of Clean Food Group's manufacturing capability and the development of next generation, high value microbial oils.
  • The funding from the UK Government's Novel Low-Emission Food Production Systems: Industrial Research Grant has been awarded by Innovate UK, the UK's national innovation agency, and the Biotechnology and Biological Sciences Research Council (BBSRC).
  • The funding will accelerate the Company's growth plan to deliver a market-ready technology leading to a more local, sustainable and healthy food production system.

Eurofins CDMO Alphora Inc. (Canada) Announces the Launch of its Biologics Initiative focusing on mAbs and Therapeutic Proteins

Retrieved on: 
Wednesday, October 4, 2023

Eurofins CDMO Alphora Inc. is pleased to announce the launch of its Biologics initiative, as part of its vision to diversify and grow within the contract development and manufacturing industry in North America.

Key Points: 
  • Eurofins CDMO Alphora Inc. is pleased to announce the launch of its Biologics initiative, as part of its vision to diversify and grow within the contract development and manufacturing industry in North America.
  • The multiphase initiative aims to establish a facility at the 2070 Hadwen site within the Sheridan Research Park campus in Mississauga, ON, Canada.
  • The $6.3M investment by Eurofins CDMO Alphora is supported by a $2.5M grant from the Ontario Government through the Ontario Together Fund (OTF).
  • Further, Eurofins CDMO Alphora’s existing API and HPAPI expertise in linker and warhead development and manufacturing will help support clients with antibody drug conjugate candidates.

BioMADE Announces Nine Projects, $18.7 Million to Advance Domestic Bioindustrial Manufacturing and DoD Sustainability Goals

Retrieved on: 
Thursday, September 14, 2023

Innovative new projects will advance sustainable food production, make DoD fleets more resilient, secure domestic supply chains for key products, and build a pipeline of trained workers.

Key Points: 
  • "These projects will help unlock the benefits of bioindustrial manufacturing for all Americans - from everyday consumers to farmers to warfighters," said Dr. Douglas Friedman, Chief Executive Officer at BioMADE.
  • Bioindustrial manufacturing harnesses the power of biology to manufacture the goods that Americans use every day.
  • By starting with feedstocks grown by American farmers, bioindustrial manufacturing creates more robust and resilient supply chains with fewer international dependencies.
  • Products such as industrial chemicals, durable fibers and fabrics, growable cement, fire-resistant composite materials, and food-grade proteins can all be produced through bioindustrial manufacturing.

Waters Launches New Walk-up Solutions that Further Simplify the Analysis of Biologic Drug Product and Cell Culture Media

Retrieved on: 
Tuesday, September 12, 2023

MILFORD, Mass., Sept. 12, 2023 /PRNewswire/ -- Waters Corporation (WAT:NYSE) announced new bioprocess walk-up solutions designed to further simplify biologic sample prep and analysis. By eliminating the need to send bioreactor samples to a central laboratory for analysis, the new solutions make it even easier to accelerate upstream bioprocess development by up to six weeks over traditional methods.i Enabled by updates to Waters OneLab™ laboratory automation software and new pre-developed analytical workflows, the combination allows bioprocess engineers to capture high-quality bioprocess and drug product data with just a few clicks.

Key Points: 
  • Updated Waters™ OneLab™ software creates new, easy-to-use walk-up solutions integrating Waters BioAccord™ LC-MS system and Andrew+™ robot with upstream bioreactors to automate routine product quality and cell culture media analyses.
  • MILFORD, Mass., Sept. 12, 2023 /PRNewswire/ -- Waters Corporation (WAT:NYSE) announced new bioprocess walk-up solutions designed to further simplify biologic sample prep and analysis.
  • Waters announced new bioprocess walk-up solutions that further simplify sample prep and analysis from any bioreactor.
  • It is designed to enable less experienced LC-MS users to acquire critical quality attribute (CQA) data for analysis of drug product and cell culture media.

Waters Launches New Walk-up Solutions that Further Simplify the Analysis of Biologic Drug Product and Cell Culture Media

Retrieved on: 
Tuesday, September 12, 2023

MILFORD, Mass., Sept. 12, 2023 /PRNewswire/ -- Waters Corporation (WAT:NYSE) announced new bioprocess walk-up solutions designed to further simplify biologic sample prep and analysis. By eliminating the need to send bioreactor samples to a central laboratory for analysis, the new solutions make it even easier to accelerate upstream bioprocess development by up to six weeks over traditional methods.i Enabled by updates to Waters OneLab™ laboratory automation software and new pre-developed analytical workflows, the combination allows bioprocess engineers to capture high-quality bioprocess and drug product data with just a few clicks.

Key Points: 
  • Updated Waters™ OneLab™ software creates new, easy-to-use walk-up solutions integrating Waters BioAccord™ LC-MS system and Andrew+™ robot with upstream bioreactors to automate routine product quality and cell culture media analyses.
  • MILFORD, Mass., Sept. 12, 2023 /PRNewswire/ -- Waters Corporation (WAT:NYSE) announced new bioprocess walk-up solutions designed to further simplify biologic sample prep and analysis.
  • It is designed to enable less experienced LC-MS users to acquire critical quality attribute (CQA) data for analysis of drug product and cell culture media.
  • Waters bioprocess walk-up solutions are now available worldwide through Waters.

Lathrop GPM LLP Intellectual Property Partner James H. Velema Receives Recognition from Massachusetts Lawyers Weekly

Retrieved on: 
Thursday, August 17, 2023

BOSTON, Aug. 16, 2023 /PRNewswire-PRWeb/ -- Lathrop GPM LLP is proud to announce that Partner James H. Velema has been named in Massachusetts Lawyers Weekly's list of Massachusetts Go To Lawyers: Intellectual Property 2023.

Key Points: 
  • Velema was named in Massachusetts Lawyers Weekly's Go To Lawyers: Intellectual Property 2023
    BOSTON, Aug. 16, 2023 /PRNewswire-PRWeb/ -- Lathrop GPM LLP is proud to announce that Partner James H. Velema has been named in Massachusetts Lawyers Weekly's list of Massachusetts Go To Lawyers: Intellectual Property 2023 .
  • Massachusetts Go To Lawyers debuted in 2020 as an effort to showcase leaders in the Massachusetts legal community by practice area.
  • "I am honored to be included among the top intellectual property legal professionals in our region," said Velema.
  • Before joining Lathrop GPM's Boston office as a founding partner, he was a partner at a Boston IP boutique specializing in Life Sciences IP.

Agilent Announces Thought Leader Award to Peter Neubauer

Retrieved on: 
Thursday, August 3, 2023

Agilent Technologies Inc. (NYSE: A) announced that Dr. Peter Neubauer has been selected to receive a prestigious Agilent Thought Leader Award.

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) announced that Dr. Peter Neubauer has been selected to receive a prestigious Agilent Thought Leader Award.
  • The Agilent Thought Leader Award will support his ongoing research into understanding and optimizing bioprocesses for difficult-to-express proteins and the development of scale-up/scale-down strategies.
  • “His important work will help the pharmaceutical industry optimize their bioprocesses and accelerate improved healthcare worldwide.”
    The Agilent Thought Leader Award program promotes fundamental scientific advances by contributing financial support, products, and expertise to the research of influential thought leaders in the life sciences, diagnostics, and chemical analysis space.
  • To learn more, visit the Agilent Thought Leader Award website.

Nick Armstrong Named CAI's Initial Senior Director of Digital Enablement

Retrieved on: 
Friday, February 3, 2023

INDIANAPOLIS, Feb. 3, 2023 /PRNewswire/ -- Commissioning Agents Inc. (CAI) announced  Nick Armstrong has been named the Initial Senior Director of Digital Enablement, as CAI continues our investment in Digital Transformation for both our internal programs and our clients' operations.

Key Points: 
  • INDIANAPOLIS, Feb. 3, 2023 /PRNewswire/ -- Commissioning Agents Inc. (CAI) announced  Nick Armstrong has been named the Initial Senior Director of Digital Enablement, as CAI continues our investment in Digital Transformation for both our internal programs and our clients' operations.
  • Mr. Armstrong has 15 years of experience in the Biopharmaceutical, Food, and Personal Care industries – with innovation and digital enablement as the throughline.
  • The supply chain and regulatory complexities for this mission require a connected voice", Mr. Armstrong Nick explained.
  • "I'm excited to have Nick join the technology team and for the official establishment of Director of Digital Enablement role," stated Jackie Karceski, Chief Technology Officer of CAI.

Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa

Retrieved on: 
Wednesday, November 30, 2022

This standout agreement with Bioventure enables selected Alvotech products to boost our regional and continental strategy and elevates access to complex medicines."

Key Points: 
  • This standout agreement with Bioventure enables selected Alvotech products to boost our regional and continental strategy and elevates access to complex medicines."
  • Licensed biosimilar candidates cover a wide range of therapeutic areas, all characterized by high unmet medical need in the Territory.
  • Bioventure is currently the Middle East and Africa's exclusive license holder for a comprehensive portfolio of biosimilar candidates developed and manufactured by Alvotech, a global biotech company headquartered in Iceland.
  • MiGenTrawas founded in 2021.MiGenTra combines the scientific and manufacturing expertise from both contributing companies, ProBioGen and Minapharm Pharmaceuticals.

Paris-based startup Gourmey uses the Big Idea Ventures accelerator program as a launch pad and goes on to raise the world’s largest cultivated meat series A

Retrieved on: 
Tuesday, October 11, 2022

This is the worlds largest Series A round for a cultivated meat startup.

Key Points: 
  • This is the worlds largest Series A round for a cultivated meat startup.
  • Gourmey joined the Big Idea Ventures accelerator program in 2019.
  • The global program facilitated the Paris-based startups move to Singapore, where it worked closely with a dedicated Big Idea Ventures team to lay the foundation for its success.
  • Big Idea Ventures is a venture firm focused on solving the world's greatest challenges by backing the world's best entrepreneurs, scientists and engineers.